<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03047967</url>
  </required_header>
  <id_info>
    <org_study_id>C15-60</org_study_id>
    <nct_id>NCT03047967</nct_id>
  </id_info>
  <brief_title>Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns</brief_title>
  <official_title>Effets du Tabagisme in Utero Sur la fonctionnalité de l'épithelium Respiratoire et Sur la Fonction Ventilatoire du Nouveau-né.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite public campaigns to prevent cigarette smoking, it's about 20% of women who keep on
      smoking during pregnancy, exposing their fetus to prenatal tobacco adverse effects. Although
      environnemental tobacco smoke exposure effects are well known, consequences of prenatal
      tobacco smoke exposure (PTSE) need better caracterization. Previous animal study from our
      group have shown, in prenatal nicotine exposed mouse pups, alterations in tracheal epithelial
      structure similar to those observed in KO α7-nAChR mouse pups. These findings support the
      hypothesis that α7-nAChR are involved in the process of deleterious effects of tobacco
      smoking on respiratory epithelium development. The purpose of the present clinical study is
      to compare PTSE neonates with controls according to lung function and respiratory epithelial
      functionality. At the age of 3 days, small respiratory epithelium fragments will be obtained
      from gentle nasal brushing performed under antalgic premedication according to the method we
      previously published. Epithelium samples will be used for in vitro studies of α7-nAChR and
      CFTR functionality. Between the ages of 2 and 6 weeks, lung function testing will be
      performed, by means of baby-body plethysmography.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>α7-nAChR functionnality</measure>
    <time_frame>day 3</time_frame>
    <description>calcium influx mesurements on epithelial fragments by monitoring changes in Fluo-4 fluorescence intensity.
Fluo-4 is a fluorescent dye which fluorescence is modified by its linkage to Calcium. Its fluorescence changes measurements shows calcium cellular flows.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CFTR functionality</measure>
    <time_frame>day 3</time_frame>
    <description>chlorid influx study on epithelial fragmentsby monitoring changes in spq fluorescence intensity.
sqp is a fluorescent dye which fluorescence is modified by its linkage to Chlore. Its fluorescence changes measurements shows chlore cellular flows.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function test</measure>
    <time_frame>between ages 2 and 6 week</time_frame>
    <description>baby-body plethysmography that study ventilation in asleep infants (measurement of tidal volumes, respiratory frequency, airway resistances, respiratory system compliance, maximal expiratory flows)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ciliary frequency mesurement</measure>
    <time_frame>day 3</time_frame>
    <description>On epithelial fragments. By using vidéo microscopy and select several delimited zone where ciliary frequency is measured. Then a mean freqeuncy is calculated</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Tobacco Smoking</condition>
  <condition>Lung Smokers</condition>
  <condition>Newborn</condition>
  <arm_group>
    <arm_group_label>PTSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prenatal tobacco smoke exposed newborns. Lung function test Nasal brushing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prenatal tobacco smoke non exposed newborns Lung function test Nasal brushing</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>lung function tests</intervention_name>
    <description>baby-body plethysmography</description>
    <arm_group_label>PTSE</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Nasal brushing</intervention_name>
    <description>Epithelial sample collecting for in vitro study</description>
    <arm_group_label>PTSE</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  inborn full-term neonate

          -  social security affiliation

          -  informed consent form signed by parents

        Exclusion Criteria:

          -  prematurity &lt; 35GW

          -  gemellary pregnancy

          -  Birth weight &lt; 2200 g

          -  neonatal respiratory distress syndrome (nasal oxygenotherapy &gt; 24 hours, invasive or
             noninvasive ventilation)

          -  neonatal malformation with conséquences on lung function

          -  neonatal liver or renal failure

          -  high risk of heritable lung disease

          -  contra-indication to saccharose or paracetamol antalgic use

          -  language barrier,

          -  mother refusal to declare or precise her tobacco consumption

          -  no social security cover

          -  informed consent form not signed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mathilde VIPREY, MD</last_name>
    <phone>+33(0)326783223</phone>
    <email>mviprey@chu-reims.fr</email>
  </overall_contact>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

